SEVERE GASTRITIS AND DUODENITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A MULTICENTER STUDY

Clément Bresteau  ¹     Pauline Bonnet  ²     Caroline Robert  ³     Philippe Saiag  ³     Bruno Buecher  ⁴     Celeste Lebbe  ⁵     Matthieu Allez  ⁵     Robert Benamouzig  ⁶     Hervé Hagège  ⁷     Hakim Bécheur  ⁸     Antoine Meyer  ⁸     Franck Carbonnel  ^8    
1 Bicêtre Hospital, Paris Saclay University, Le Kremlin-Bicêtre, France
² Ambroise Pare Hospital, Université Versailles Saint-Quentin-en-Yvelines, Boulogne-Billancourt, France
³ Institut Gustave Roussy, Paris Saclay University, Villejuif, France
⁴ Institut Curie, PSL Research University, Paris, France
⁵ Saint Louis Hospital, Paris University, Paris, France
⁶ Avicenne Hospital, Sorbonne Paris Nord University, Bobigny, France
⁷ Hôpital Intercommunal de Créteil, Créteil, France
⁸ Bichat-Claude Bernard Hospital, Paris University, Paris, France

Session
Oesophageal, gastric and duodenal disorders (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)